These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8318674)

  • 1. Pulmonary edema and shock after high-dose aracytine-C for lymphoma; possible role of TNF-alpha and PAF.
    Chiche D; Pico JL; Bernaudin JF; Chouaib S; Wollman E; Arnoux A; Denizot Y; Nitenberg G
    Eur Cytokine Netw; 1993; 4(2):147-51. PubMed ID: 8318674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha.
    Laurenzi L; Natoli S; Di Filippo F; Calamaro A; Centulio F; Anzà M; Cavaliere F; Marcelli ME; Garinei R; Arcuri E
    J Exp Clin Cancer Res; 2004 Jun; 23(2):225-31. PubMed ID: 15354406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meconium enhances platelet-activating factor and tumor necrosis factor production by rat alveolar macrophages.
    Berdeli A; Akisu M; Dagci T; Akisu C; Yalaz M; Kultursay N
    Prostaglandins Leukot Essent Fatty Acids; 2004 Oct; 71(4):227-32. PubMed ID: 15301793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological status of septic and trauma patients. I. High tumor necrosis factor alpha serum levels in septic and trauma patients are not responsible for increased mortality; a prognostic value of serum interleukin 6.
    Adamik B; Zimecki M; Właszczyk A; Kübler A
    Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):169-75. PubMed ID: 9597083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxaliplatin may induce cytokine-release syndrome in colorectal cancer patients.
    Tonini G; Santini D; Vincenzi B; Borzomati D; Dicuonzo G; La Cesa A; Onori N; Coppola R
    J Biol Regul Homeost Agents; 2002; 16(2):105-9. PubMed ID: 12144121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of tumor metastasis by platelet-activating factor.
    Im SY; Ko HM; Kim JW; Lee HK; Ha TY; Lee HB; Oh SJ; Bai S; Chung KC; Lee YB; Kang HS; Chun SB
    Cancer Res; 1996 Jun; 56(11):2662-5. PubMed ID: 8653713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation in septic shock: hydrocortisone differentially regulates cytokine responses.
    Briegel J; Jochum M; Gippner-Steppert C; Thiel M
    J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S70-4. PubMed ID: 11251036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C; Van Molle W; Brouckaert P; Fiers W
    J Inflamm; 1995-1996; 46(3):139-43. PubMed ID: 8844494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta1 blocks in vitro cardiac myocyte depression induced by tumor necrosis factor-alpha, interleukin-1beta, and human septic shock serum.
    Kumar A; Kumar A; Paladugu B; Mensing J; Parrillo JE
    Crit Care Med; 2007 Feb; 35(2):358-64. PubMed ID: 17204997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional analysis of pulmonary microvascular endothelial cells from patients with acute respiratory distress syndrome.
    Grau GE; Mili N; Lou JN; Morel DR; Ricou B; Lucas R; Suter PM
    Lab Invest; 1996 Apr; 74(4):761-70. PubMed ID: 8606486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemolytic uraemic syndrome and renal dysfunction following BEAC (BCNU, etoposide, ara-C, cyclophosphamide) +/- TBI and autologous BMT for malignant lymphomas.
    Carlson K; Smedmyr B; Hagberg H; Oberg G; Simonsson B
    Bone Marrow Transplant; 1993 Mar; 11(3):205-8. PubMed ID: 8467284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute renal failure in the transretinoic syndrome].
    Sastre A; Gago E; Baños M; Gómez E
    Nefrologia; 2007; 27(2):184-90. PubMed ID: 17564563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
    Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
    Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
    Iglesias J; Marik PE; Levine JS;
    Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell dynamics and expression of tumor necrosis factor (TNF)-alpha, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma.
    Yamaguchi S; Kitagawa M; Inoue M; Tomizawa N; Kamiyama R; Hirokawa K
    Exp Mol Pathol; 2000 Apr; 68(2):85-94. PubMed ID: 10716912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.
    Tarella C; Di Nicola M; Caracciolo D; Zallio F; Cuttica A; Omedè P; Bondesan P; Magni M; Matteucci P; Gallamini A; Pileri A; Gianni AM
    Bone Marrow Transplant; 2002 Dec; 30(11):725-32. PubMed ID: 12439694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis.
    He J; Bazan HE
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):883-91. PubMed ID: 16505020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.